X4 Pharmaceuticals, Inc (XFOR) insider trading
X4 Pharmaceuticals, Inc insiders have made 1 open-market purchase worth $12k since Oct 19, 2026, by 1 insider. The latest: Adam R. Craig (Chair) bought $12k, filed Oct 19, 2026, scored 32 out of 100.
Follow XFOR, freeOpen the live feed
A free account gets an alert the minute a new buy or sale is filed.
Insider purchases
| Filed | Insider | Stake | Score | Bought | 1 week | 1 month |
|---|---|---|---|---|---|---|
| Oct 19 Form 4 (opens sec.gov) |
Adam R. CraigChairChair · Near 52-week low | +1% stake | 32 | $12k 4,600 at $2.58 |
— | — |
Insider sales
1 open-market sale on record
| Filed | Insider | Sold |
|---|---|---|
| Oct 5 Form 4 (opens sec.gov) |
David KirskeCFO | $34k 11,767 at $2.86 · 7% of holdings |
Most insider sales are planned in advance or made for personal reasons, so a sale says less than a buy.
Insiders who bought XFOR
- Adam R. Craig Chair
Questions
Are insiders buying XFOR stock?
Yes. In the last 90 days, 1 open-market purchase was filed, worth $12k, against $34k of open-market sales.
Who bought XFOR stock most recently?
Adam R. Craig, Chair, bought 4,600 shares for $12k (Form 4 (opens sec.gov), filed Oct 19, 2026).
How does InsiderBeacon score an insider buy?
Out of 100, from who bought, how much their stake grew, the size of the trade, whether other insiders bought within ten days, where the price sat in its 52-week range, and whether it was a first or a routine buy. The score is fixed when the filing arrives. The formula and the research behind it.
Insiders are also buying, same industry
Data as of Oct 19, 2026, from SEC EDGAR Form 4 filings: open-market purchases (code P) of $25,000 or more, and open-market sales. Every row links to its filing. Scores summarise what a filing says (how the score works); outcomes are hypothetical, from the first close after the filing, and past results don't predict future ones. Disclaimer